Most recent comments


See all comments
Leave your own comments

Nickname: Djaja Stephanie
Review: Interesting information. Added value of research for the patient-stakeholder.
Date reviewed: Feb 15, 2008 5:18 AM
Nickname: Kirk
Review: Brilliant. The strategy is akin to the Internet idea of sharing, and reminds me of pieces of strategy from enterprises such as Linux and Adobe. Great to see a firm looking across medical areas.
Date reviewed: Mar 1, 2006 2:20 PM
Nickname: kushitushit
Review: Now I understand why Novartis has come out with a number of "orphan drugs," one of which saved an acquaintance of mine. Drug companies are always looking for the "big score" or the $3 million drug. This is great what Novartis is doing.
Date reviewed: Feb 23, 2006 6:40 PM
See all comments
Leave your own comments



The views and opinions expressed in these comments do not necessarily reflect the views or opinions of BusinessWeek or the McGraw-Hill Companies.